101 related articles for article (PubMed ID: 15781479)
1. Idiopathic urinary stone disease: possible polygenic aetiological factors.
Watts RW
QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
[No Abstract] [Full Text] [Related]
2. Urinary kidney stone inhibitors. Where are we?
Dussol B; Berland Y
Nephrol Dial Transplant; 1996 Jul; 11(7):1222-4. PubMed ID: 8672008
[No Abstract] [Full Text] [Related]
3. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
4. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis.
Cailhier JF; Petrucci M; Valiquette L; Guay G; Ouimet D; Bonnardeaux A
J Urol; 2001 Oct; 166(4):1484-6. PubMed ID: 11547117
[TBL] [Abstract][Full Text] [Related]
5. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
Marengo SR; Resnick MI; Yang L; Chung JY
J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
[TBL] [Abstract][Full Text] [Related]
7. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
Atmani F; Mizon J; Khan SR
Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
[TBL] [Abstract][Full Text] [Related]
8. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro.
Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R
Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
Grover PK; Moritz RL; Simpson RJ; Ryall RL
Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
[TBL] [Abstract][Full Text] [Related]
10. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
Atmani F; Glenton PA; Khan SR
Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.
Ryall RL
Pediatr Nephrol; 1996 Oct; 10(5):656-66. PubMed ID: 8897580
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitors in calcium oxalate crystals].
Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):411-20. PubMed ID: 10349299
[No Abstract] [Full Text] [Related]
13. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
Penniston KL; Nakada SY
Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
[TBL] [Abstract][Full Text] [Related]
14. Expression of a functional proteinase inhibitor capable of accepting xylose: bikunin.
Falkenberg C; Wester L; Belting M; Eklund E; Akerström B
Arch Biochem Biophys; 2001 Mar; 387(1):99-106. PubMed ID: 11368189
[TBL] [Abstract][Full Text] [Related]
15. Genetic factors in calcium oxalate stone disease.
Goodman HO; Holmes RP; Assimos DG
J Urol; 1995 Feb; 153(2):301-7. PubMed ID: 7815569
[No Abstract] [Full Text] [Related]
16. Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin.
Stapleton AM; Ryall RL
Br J Urol; 1995 Jun; 75(6):712-9. PubMed ID: 7613825
[TBL] [Abstract][Full Text] [Related]
17. Gene expression of prothrombin in the human kidney and its potential relevance to kidney stone disease.
Stapleton AM; Timme TL; Ryall RL
Br J Urol; 1998 May; 81(5):666-71; discussion 671-2. PubMed ID: 9634038
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of calcium phosphate-associated proteins on calcium oxalate crystallization: alpha2-HS-glycoprotein, prothrombin-F1 and osteopontin.
Nishio S; Iseda T; Takeda H; Iwata H; Yokoyama M
BJU Int; 2000 Sep; 86(4):543-8. PubMed ID: 10971289
[TBL] [Abstract][Full Text] [Related]
19. Uromucoids and urinary stone formation.
Hallson PC; Rose GA
Lancet; 1979 May; 1(8124):1000-2. PubMed ID: 86719
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
